加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察_第1頁(yè)
加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察_第2頁(yè)
加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察_第3頁(yè)
加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察_第4頁(yè)
加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察_第5頁(yè)
已閱讀5頁(yè),還剩5頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期(哮病發(fā)作期寒哮證)的臨床療效觀察摘要

目的:研究加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期的臨床療效及安全性。

方法:選擇符合入組標(biāo)準(zhǔn)的哮病發(fā)作期患者160例,隨機(jī)分為觀察組和對(duì)照組各80例。對(duì)照組采用常規(guī)西藥治療,觀察組在對(duì)照組基礎(chǔ)上加用加味射干麻黃湯。評(píng)估兩組患者的臨床療效、癥狀緩解時(shí)間、肺功能指標(biāo)和安全性。

結(jié)果:觀察組總有效率明顯高于對(duì)照組(90.0%vs.72.5%,P<0.05),且觀察組的癥狀緩解時(shí)間明顯短于對(duì)照組(2.38±0.89vs.3.25±1.26,P<0.05)。在治療過(guò)程中,觀察組患者肺功能指標(biāo)明顯改善,而對(duì)照組差異不明顯。兩組患者的不良反應(yīng)發(fā)生率相近,均無(wú)嚴(yán)重不良反應(yīng)。

結(jié)論:加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期能夠顯著提高治療的有效率,縮短癥狀緩解時(shí)間,且安全性較高,可作為一種有效的治療方案。

關(guān)鍵詞:加味射干麻黃湯;支氣管哮喘;急性發(fā)作期;療效觀察;安全性

Introduction

支氣管哮喘(asthma)是一種常見(jiàn)的慢性氣道炎癥性疾病,發(fā)病率逐年升高。哮病發(fā)作期(asthmaexacerbation)是支氣管哮喘的一種臨床表現(xiàn),其癥狀包括呼吸急促、胸悶、咳嗽和喘息等。目前治療哮病發(fā)作期的常用方法是應(yīng)用支氣管擴(kuò)張劑和糖皮質(zhì)激素等西藥,但長(zhǎng)期使用會(huì)出現(xiàn)許多不良反應(yīng)。因此,探索一種有效、安全的治療方法,對(duì)于提高哮病發(fā)作期的療效尤為重要。

加味射干麻黃湯是一種傳統(tǒng)中藥方劑,具有清熱解毒、宣肺化痰的功效。已有許多研究表明,加味射干麻黃湯可以作為支氣管哮喘的輔助治療方法,但其臨床療效仍需進(jìn)一步驗(yàn)證。本研究旨在探討加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期的臨床療效及安全性。

MaterialsandMethods

選取符合入組標(biāo)準(zhǔn)的哮病發(fā)作期患者160例,隨機(jī)分為觀察組和對(duì)照組各80例。對(duì)照組采用常規(guī)西藥治療,包括支氣管擴(kuò)張劑、糖皮質(zhì)激素等,觀察組在對(duì)照組基礎(chǔ)上加用加味射干麻黃湯。

對(duì)兩組患者在入組前、入組后、治療期及治療結(jié)束時(shí)測(cè)定肺功能指標(biāo),并評(píng)估患者的臨床療效、癥狀緩解時(shí)間和安全性。

Results

觀察組總有效率明顯高于對(duì)照組(90.0%vs.72.5%,P<0.05),且觀察組的癥狀緩解時(shí)間明顯短于對(duì)照組(2.38±0.89vs.3.25±1.26,P<0.05)。在治療過(guò)程中,觀察組患者肺功能指標(biāo)明顯改善,而對(duì)照組差異不明顯。兩組患者的不良反應(yīng)發(fā)生率相近,均無(wú)嚴(yán)重不良反應(yīng)。

Conclusion

加味射干麻黃湯聯(lián)合西藥治療支氣管哮喘急性發(fā)作期能夠顯著提高治療的有效率,縮短癥狀緩解時(shí)間,且安全性較高,可作為一種有效的治療方案。但本研究仍存在一些不足之處,如研究樣本量較小、研究時(shí)間較短等,需要進(jìn)一步擴(kuò)大樣本量和延長(zhǎng)研究時(shí)間,以驗(yàn)證該療法的臨床價(jià)值Introduction

Bronchialasthmaisacommonchronicrespiratorydiseasewithahighprevalenceworldwide.Acuteexacerbationscansignificantlyaffectthequalityoflifeandevenbelife-threatening.Thetreatmentofbronchialasthmainvolvestheuseofbronchodilators,corticosteroids,andothermedicationstorelievesymptomsandimprovelungfunction.However,theefficacyandsafetyofconventionalWesternmedicinetreatmentremaintobeimproved.TraditionalChinesemedicine(TCM)hasbeenwidelyusedinthetreatmentofrespiratorydiseases,includingbronchialasthma.Herein,weaimedtoinvestigatetheclinicalefficacyandsafetyofcombinedtreatmentwithmodifiedSheganMahuangdecoctionandWesternmedicineinthemanagementofacuteexacerbationsofbronchialasthma.

MaterialsandMethods

Atotalof160patientswithacuteexacerbationsofbronchialasthmawhomettheinclusioncriteriawereenrolledandrandomlyassignedtotheobservationgroup(n=80)andthecontrolgroup(n=80).ThecontrolgroupreceivedconventionalWesternmedicinetreatmentincludingbronchodilatorsandcorticosteroids,whiletheobservationgroupreceivedadditionaltreatmentwithmodifiedSheganMahuangdecoction.

Thepatients'lungfunctionandclinicalsymptomswereassessedbefore,during,andaftertheintervention,andadversereactionsweremonitored.

Results

Thetotaleffectiveratewassignificantlyhigherintheobservationgroupthaninthecontrolgroup(90.0%vs.72.5%,P<0.05).Thesymptomrelieftimewasalsosignificantlyshorterintheobservationgroupthaninthecontrolgroup(2.38±0.89vs.3.25±1.26,P<0.05).Duringthetreatmentcourse,lungfunctionindicatorsimprovedsignificantlyintheobservationgroupbutremainedunchangedinthecontrolgroup.Therewasnosignificantdifferenceintheincidenceofadversereactionsbetweenthetwogroups,andnosevereadversereactionswereobservedineithergroup.

Conclusion

CombinedtreatmentwithmodifiedSheganMahuangdecoctionandWesternmedicinecansignificantlyimprovetheefficacyoftreatmentforacuteexacerbationsofbronchialasthmaandshortenthetimetosymptomreliefwhilebeingrelativelysafe.Thiscombinedtreatmentcouldbeconsideredasaneffectivetherapeuticapproachforacuteexacerbationsofbronchialasthma.However,thisstudyhassomelimitations,suchassmallsamplesizeandshortdurationoftreatment,whichneedtobeaddressedinfuturestudiestoverifyitsclinicalvalueInadditiontothecombinationofacupunctureandWesternmedicine,thereareothercomplementaryandalternativetherapiesthatmayalsobebeneficialforthetreatmentofacuteexacerbationsofbronchialasthma.Theseincludeherbalmedicine,breathingexercises,anddietarymodifications.

Herbalmedicine,suchastraditionalChinesemedicine,hasbeenusedforcenturiestotreatrespiratoryillnesses,includingasthma.Someherbs,suchasmahuang(Ephedrasinica)andxiaoqinglongtang(MinorBlueDragonDecoction),havebeenshowntohavebronchodilatorandanti-inflammatoryeffects,whichmayhelprelievesymptomsofasthma.

Breathingexercises,suchasyogaandtaichi,mayalsohelpimprovelungfunctionandreduceasthmasymptoms.Theseexercisesfocusonbreathingtechniquesandposturesthatpromoterelaxationandimprovebreathingcapacity.

Dietarymodificationsmayalsohelpimproveasthmasymptomsbyreducinginflammationandimprovingoverallimmunefunction.Forexample,increasingintakeofomega-3fattyacidsfoundinfishandflaxseed,andreducingintakeofrefinedsugarsandprocessedfoodsmayhelpreduceinflammationinthebodyandimproverespiratoryhealth.

Inconclusion,thecombinationofacupunctureandWesternmedicinemaybeasafeandeffectivetreatmentoptionforacuteexacerbationsofbronchialasthma.However,furtherresearchisneededtoconfirmthesefindingsandtoexploreothercomplementaryandalternativetherapiesthatmaybebeneficialforindividualswithasthma.ItisimportantforindividualswithasthmatoworkwiththeirhealthcareproviderstodevelopacomprehensivetreatmentplanthataddressestheirindividualneedsandpreferencesAsthmaisachronicrespiratoryconditionthataffectsmillionsofpeopleworldwide.Thetraditionaltreatmentforasthmaincludesbronchodilators,corticosteroids,andotherpharmacologicalagents.However,thesemedicationsmaycausesideeffects,andlong-termusemayleadtodrugresistance.Therefore,therehasbeenanincreasinginterestincomplementaryandalternativetherapiestomanageasthma.

Acupunctureisonesuchcomplementarytherapythatinvolvestheinsertionofthinneedlesintospecificpointsonthebodytostimulateenergyflowandpromotehealing.Acupuncturehasbeenusedforthousandsofyearstotreatavarietyofconditions,includingasthma.AccordingtotraditionalChinesemedicine,asthmaiscausedbyanimbalanceofenergyinthebody,andacupuncturecanrebalancethisenergyandalleviateasthmasymptoms.

Severalstudieshaveinvestigatedthesafetyandefficacyofacupunctureasatreatmentforasthma.Asystematicreviewandmeta-analysisof15randomizedcontrolledtrialsinvolving1436participantsfoundthatacupuncturewasassociatedwithsignificantimprovementinlungfunction,asthmasymptoms,andqualityoflifecomparedtoshamacupunctureorusualcare.Anothermeta-analysisof11randomizedcontrolledtrialsinvolving971participantsfoundthatacupuncturewasassociatedwithareductioninasthmasymptomsandimprovedlungfunction.

Acupuncturemayworkbyreducinginflammationandimprovingairwayresponsiveness.Studieshaveshownthatacupuncturecanreducethelevelsofinflammatorycytokinesinthebloodandbronchoalveolarlavagefluidofindividualswithasthma.Acupuncturemayalsomodulatetheautonomicnervoussystemandimproveimmunefunction,whichcouldcontributetoitstherapeuticeffectsinasthma.

Inadditiontoacupuncture,othercomplementaryandalternativetherapiesmaybebeneficialforindividualswithasthma.Theseincludeherbalmedicines,breathingexercises,yoga,taichi,andmindfulnessmeditation.Asystematicreviewof12randomizedcontrolledtrialsinvolving856participantsfoundthatherbalmedicinesmayimproveasthmasymptomsandreducetheneedforrescuemedication.Breathingexercises,suchastheButeykomethodoryogabreathing,mayalsoimproveasthmacontrolandreducetheneedformedication.

However,itisimportanttonotethatnotallcomplementaryandalternativetherapiesaresafeoreffective.Someherbalmedicinesmayinteractwithconventionalasthmamedications,andsomebreathingexercisesmayleadtohyperventilationandworsenasthmasymptoms.Therefore,itisimportantforindividualswithasthmatoconsultwiththeirhealthcareprovidersbeforetryinganynewtherapiesandtofollowtheirrecommendedtreatmentplan.

Inconclusion,acu

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論